2024 ASM Microbe

Join thousands of scientists, researchers and healthcare professionals in your field, who are all traveling to Atlanta, June 13-17, for the largest microbial sciences gathering in the world! Peter Hotez, M.D., Ph.D., CDC Director Mandy Cohen and MSNBC’s Jonathan Capehart are just some of the world-renowned speakers lined up in ASM Microbe’s cutting-edge scientific program.

ASM Microbe 2024 Features

Our experts have curated groundbreaking scientific sessions on topics that are shaping the future of humanity. From the bioeconomy to microbiome research, we have something for everyone. Here is a list of just a few of the cutting-edge topics for all:

• Global Health.
• Industry Focus.
• Health Disparities.
• Antimicrobial Resistance-Basic Science.
• Phage Biology & Therapy.
• AI and Molecular Modeling.
• And so much more.

Standard Registration Deadline: May 24

Visit Illumina booth 1015 to learn more about our solutions in microbial sciences.

_________________________________________________________________________________________________

Friday, June 14 at 11 AM (ET) in Exhibit Hall–Theater B

Broad detection of clinically relevant respiratory pathogens by targeted next-generation sequencing

Sequencing can improve detection of respiratory pathogens particularly in the case of rare organisms and polymicrobial infections. In this practical presentation, Dr. Sharon Kuss-Duerkop will discuss experimental design, assay optimization, and performance of the Illumina Respiratory Pathogen ID/AMR Panel Kit (RPIP; RUO*) based on a proof-of-principle study modeling polymicrobial specimens with pools of diverse pathogens spiked-in to artificial sputum matrix. Join us to hear how this assay and analysis application were employed in a molecular microbiology laboratory without dedicated bioinformatics expertise.

Sharon Kuss-Duerkop, PhD
Senior Scientist | Strategic Innovation
Advanced Diagnostic Laboratories 

Saturday, June 15 at 1 PM (ET) in Exhibit Hall–Theater B

Solutions for Sequencing-Based Pathogen and Antimicrobial Resistance (AMR) Identification and Profiling; Single-Pathogen, Multi-Pathogen, and Agnostic Approaches

Advancements in sequencing technologies have completely transformed the way we identify and study microorganisms. Thanks to Next-generation sequencing-based methods, such as single-pathogen, multi-pathogen, and agnostic methods, we can now analyze complex microbial communities and detect multiple pathogens simultaneously without culturing. NGS has not only enhanced our understanding of infectious diseases but also has significant implications for developing targeted treatment strategies and surveillance programs. Learn more about the boundless potential of NGS in unraveling the mysteries of microbes.

Robert Schlaberg, MD, PhD
Vice President Applications & Concierge Department and Distinguished Scientist
Illumina